Showing results (1381-1390 of 1,594) with videos related to
Sort By:
Pageof 160
Plos One|September 15, 2015
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated MenZoe Moodie, Barbara Metch, Linda-Gail Bekker, et al.Physical Review Letters|April 7, 2010
Surface-stabilized nonferromagnetic ordering of a layered ferromagnetic manganiteV B Nascimento, J W Freeland, R Saniz, et al.Journal of Shoulder and Elbow Surgery|February 28, 2026
Return to Weightlifting After Shoulder Arthroplasty: An ASES Multicenter Study Predicting Performance after Reverse Shoulder Arthroplasty (rTSA) and Anatomic Shoulder Arthroplasty (aTSA)Declan R Diestel, Suleiman Sudah, Nick Veale, et al.JMIR Formative Research|September 6, 2022
A Method to Deliver Automated and Tailored Intervention Content: 24-month Clinical TrialHailey N Miller, Corrine I Voils, Kate A Cronin, et al.Journal of Paediatrics and Child Health|October 13, 2021
COVID-19 in children: I. Epidemiology, prevention and indirect impactsAnnaleise R Howard-Jones, Asha C Bowen, Margie Danchin, et al.The New Phytologist|January 3, 2018
The BIG protein distinguishes the process of CO<sub>2</sub> -induced stomatal closure from the inhibition of stomatal opening by CO<sub>2</sub>Jingjing He, Ruo-Xi Zhang, Kai Peng, et al.Nature Plants|November 29, 2016
Origin and function of stomata in the moss Physcomitrella patensCaspar C Chater, Robert S Caine, Marta Tomek, et al.The Lancet. Infectious Diseases|February 25, 2014
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili studyGlenda E Gray, Zoe Moodie, Barbara Metch, et al.Infection Control and Hospital Epidemiology|November 10, 2018
Variability in antimicrobial use in pediatric ventilator-associated eventsManjiree V Karandikar, Susan E Coffin, Gregory P Priebe, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 30, 2024
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus ChemotherapyMaximilian Hochmair, Michael Schenker, Manuel Cobo Dols, et al.Pageof 160